Exploratory analysis of gut microbiome as a novel biomarker in patients with advanced thymic carcinoma on immunochemotherapy
Not Applicable
- Conditions
- thymic carcinoma
- Registration Number
- JPRN-UMIN000053154
- Lead Sponsor
- Yusuke Okuma, National Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether the composition of the intestinal flora is a predictive factor
- Secondary Outcome Measures
Name Time Method Whether plasma biomarkers are predictive factors